Graphite Bio slips after downgrade by BofA Securities

Jan. 18, 2023 1:14 PM ETGraphite Bio, Inc. (GRPH)By: Preeti Singh, SA News Editor
  • Graphite Bio (NASDAQ:GRPH) was down around -9% on Wednesday after BofA Securities downgraded the stock to Neutral from Buy, with a price target of $3 (down from $7).
  • BofA Securities analysts cited "uncertainty surrounding the development timeline" of its sickle cell candidate nula-cel and "a

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.